Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Beaver › NPI 1063422053
Hospital

Valley Medical Facilities INC

Valley Medical Facilities INC was paid $10.29M by Medicaid between Jan 2018 and Dec 2024, across 303 billing codes. Its largest line is 99284, emergency room visit (serious) — 24% of everything it billed.

33Billing provider infoVALLEY MEDICAL FACILITIES INC
BEAVER, PA 15009
33aNPI1063422053assigned 08/09/2006
28Total paid$10.29M
24GClaims396,571
24DCodes billed303
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#30 of 154
Median peer was paid$2.82M
This provider vs. median3.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018949$32K
20191,212$20K
202038,472$764K
2021211,505$4.98M
202254,865$1.57M
202361,673$1.94M
2024incomplete27,895$987K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 24% 24,574 21,670 $2.49M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 12% 17,044 15,039 $1.20M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 10% 9,330 8,390 $1.08M
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 6.3% 7,178 6,798 $648K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 3.7% 10,221 6,527 $378K
G0378 Hospital observation service, per hour 3.6% 1,493 657 $375K
80053 Comprehensive metabolic panel 2.5% 25,515 23,541 $262K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.9% 1,160 1,133 $200K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.6% 6,499 6,187 $168K
D2930 Prefabricated stainless steel crown - primary tooth 1.4% 171 149 $146K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.4% 1,467 1,448 $142K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.3% 26,065 23,493 $137K
291 more codes
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.1% 3,743 $118K
84443 Thyroid stimulating hormone (TSH) <1% 4,117 $93K
80061 Lipid panel <1% 6,309 $88K
80050 General health panel <1% 1,606 $83K
71046 Radiologic examination, chest; 2 views <1% 5,595 $83K
70450 Computed tomography, head or brain; without contrast material <1% 1,418 $80K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,980 $78K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,955 $76K
71275 Computed tomographic angiography, chest, with contrast material <1% 403 $74K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 5,719 $72K
77067 Screening mammography, bilateral, including computer-aided detection <1% 828 $70K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,712 $58K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 736 $58K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 208 $55K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 6,634 $55K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,164 $53K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 228 $52K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,749 $51K
96375 Therapeutic injection; each additional sequential IV push <1% 2,923 $49K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 1,157 $44K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,060 $43K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 242 $41K
80048 Basic metabolic panel (calcium, ionized) <1% 4,995 $40K
X0621 <1% 443 $40K
85027 <1% 5,865 $38K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 151 $37K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 4,716 $35K
70551 Magnetic resonance imaging, brain; without contrast material <1% 165 $33K
72141 <1% 131 $31K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 765 $29K
73630 <1% 2,582 $29K
93971 <1% 462 $28K
83735 <1% 4,856 $27K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,383 $26K
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 672 $26K
84484 <1% 3,750 $26K
83036 Hemoglobin; glycosylated (A1C) <1% 3,524 $25K
84703 <1% 2,658 $25K
73610 <1% 1,321 $25K
72125 Computed tomography, cervical spine; without contrast material <1% 412 $24K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 468 $23K
87081 <1% 3,493 $23K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 674 $23K
71250 <1% 339 $21K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 490 $21K
81003 <1% 7,599 $21K
76830 Ultrasound, transvaginal <1% 441 $19K
77063 Screening digital breast tomosynthesis, bilateral <1% 645 $19K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 277 $18K
87481 <1% 431 $18K
76536 <1% 354 $18K
84439 <1% 2,082 $17K
83690 <1% 3,705 $17K
80074 <1% 278 $16K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 44 $16K
86318 <1% 742 $15K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 560 $15K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,176 $15K
70496 <1% 95 $14K
71045 Radiologic examination, chest; single view <1% 2,456 $14K
83880 <1% 579 $13K
82607 <1% 1,128 $13K
86780 <1% 740 $13K
97161 <1% 310 $12K
76642 <1% 307 $12K
93970 <1% 155 $11K
86618 <1% 413 $11K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 203 $11K
84702 <1% 597 $10K
83970 <1% 243 $10K
86803 <1% 488 $10K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 170 $10K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 169 $10K
82043 <1% 1,204 $10K
85730 <1% 2,059 $10K
76801 <1% 224 $10K
85610 <1% 3,239 $10K
76775 <1% 273 $9K
36415 Collection of venous blood by venipuncture <1% 38,920 $9K
70498 <1% 64 $9K
87186 <1% 1,105 $9K
86480 <1% 113 $9K
87653 <1% 195 $9K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,372 $9K
84153 <1% 337 $9K
83605 <1% 1,494 $9K
72100 <1% 438 $9K
80076 <1% 961 $9K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 398 $8K
82803 <1% 565 $8K
74018 <1% 622 $8K
87070 <1% 1,209 $8K
70486 <1% 125 $8K
82728 <1% 685 $8K
86702 <1% 578 $8K
87040 <1% 609 $8K
73560 <1% 496 $8K
86038 <1% 478 $7K
73030 <1% 489 $7K
86850 <1% 1,043 $7K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 40 $7K
82784 <1% 347 $7K
86701 <1% 578 $7K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 342 $7K
73130 <1% 551 $7K
82570 <1% 913 $7K
87340 <1% 423 $7K
77066 Tomosynthesis, mammo <1% 79 $7K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 101 $6K
0240U <1% 107 $6K
87390 <1% 578 $6K
84481 <1% 229 $6K
86762 <1% 261 $6K
87077 <1% 751 $6K
96361 Intravenous infusion, hydration; each additional hour <1% 403 $5K
82746 <1% 472 $5K
84146 <1% 200 $5K
86140 <1% 1,636 $5K
87522 Neg quan hep c or qual rna <1% 101 $5K
12001 <1% 107 $5K
84145 <1% 392 $5K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 267 $5K
93000 <1% 208 $5K
73110 <1% 369 $4K
73502 <1% 238 $4K
86665 <1% 102 $4K
86900 <1% 1,164 $4K
85651 <1% 1,309 $4K
36430 <1% 100 $4K
86901 <1% 1,158 $4K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 971 $4K
90715 <1% 431 $4K
85378 <1% 440 $4K
73221 <1% 12 $3K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 72 $3K
76641 <1% 65 $3K
82565 <1% 507 $3K
84403 <1% 91 $3K
83001 <1% 145 $3K
86706 <1% 202 $3K
74019 <1% 183 $3K
80164 <1% 154 $3K
84460 <1% 361 $3K
71271 <1% 47 $3K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 109 $2K
82550 <1% 395 $2K
84165 <1% 178 $2K
83550 <1% 503 $2K
73590 <1% 158 $2K
86431 <1% 268 $2K
86664 <1% 91 $2K
84100 <1% 446 $2K
80069 <1% 244 $2K
72110 <1% 86 $2K
84550 <1% 327 $2K
83721 <1% 236 $2K
72114 <1% 91 $2K
86663 <1% 91 $2K
84520 <1% 340 $2K
82950 <1% 235 $2K
84450 <1% 258 $2K
73080 <1% 165 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,979 $2K
83525 <1% 132 $2K
87493 <1% 40 $2K
83615 <1% 274 $2K
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion <1% 63 $1K
86235 <1% 14 $1K
83655 <1% 118 $1K
87205 <1% 362 $1K
D3220 Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction <1% 29 $1K
59025 Fetal non-stress test <1% 482 $1K
97165 <1% 90 $1K
83002 <1% 66 $1K
84681 <1% 39 $1K
72040 <1% 83 $1K
73090 <1% 113 $1K
72070 <1% 60 $1K
12011 <1% 26 $1K
82947 <1% 268 $1K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 25 $1K
84402 <1% 39 $1K
84270 <1% 40 $1K
84155 <1% 283 $1K
10060 <1% 12 $1K
96376 <1% 328 $944.68
82077 <1% 580 $922.05
85018 <1% 291 $920.88
29125 <1% 37 $903.50
83516 <1% 380 $871.61
82248 <1% 119 $853.40
86334 <1% 27 $845.98
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,448 $842.28
86200 <1% 63 $825.17
72050 <1% 27 $820.50
86376 <1% 65 $817.53
82977 <1% 101 $805.30
86160 <1% 29 $771.35
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,739 $741.93
85014 <1% 244 $739.53
86923 <1% 50 $738.20
P9016 Red blood cells, leukocytes reduced, each unit <1% 16 $728.37
84480 <1% 73 $652.02
83540 <1% 77 $649.87
82962 <1% 917 $642.89
82533 <1% 53 $639.60
71101 <1% 43 $605.85
76870 <1% 12 $598.40
77080 <1% 12 $590.11
86617 <1% 12 $535.93
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 53 $465.45
90686 <1% 149 $464.35
J2704 Injection, propofol, 10 mg <1% 3,900 $462.10
87451 <1% 44 $453.77
86308 <1% 55 $416.72
86708 <1% 26 $394.50
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 704 $392.79
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 223 $379.00
87045 <1% 57 $370.19
87046 <1% 57 $353.86
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 164 $345.98
84436 <1% 32 $333.41
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,559 $332.95
83921 <1% 15 $331.14
J3490 Unclassified drugs <1% 228 $321.20
82627 <1% 13 $315.00
87529 <1% 89 $311.64
82105 <1% 15 $306.00
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,995 $299.34
93017 <1% 13 $292.95
93922 <1% 16 $291.49
82150 <1% 57 $285.21
73562 <1% 15 $257.31
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 361 $249.70
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 12 $224.70
84156 <1% 72 $217.33
82140 <1% 62 $216.58
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,042 $176.33
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 758 $171.49
A6209 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 128 $165.57
76857 <1% 12 $152.48
73140 <1% 15 $147.50
G0008 Administration of influenza virus vaccine <1% 18 $138.27
88304 <1% 59 $127.93
80178 <1% 12 $115.20
81513 <1% 253 $113.10
J0690 Injection, cefazolin sodium, 500 mg <1% 672 $106.19
J1170 Injection, hydromorphone, up to 4 mg <1% 114 $104.51
J1644 Injection, heparin sodium, per 1000 units <1% 463 $91.50
88314 <1% 102 $85.06
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,295 $84.57
J2060 Injection, lorazepam, 2 mg <1% 259 $70.34
94010 <1% 13 $69.30
85045 <1% 14 $57.96
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 523 $55.25
82010 <1% 17 $53.50
80179 <1% 47 $51.72
J1741 Injection, ibuprofen, 100 mg <1% 148 $50.60
76882 <1% 13 $49.26
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 299 $39.93
85049 <1% 43 $38.10
85660 <1% 14 $36.08
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,974 $18.69
J1630 Injection, haloperidol, up to 5 mg <1% 18 $13.41
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 52 $11.27
87324 <1% 25 $9.50
87449 <1% 54 $9.50
J3475 Injection, magnesium sulfate, per 500 mg <1% 53 $8.60
J1815 Injection, insulin, per 5 units <1% 84 $7.86
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 202 $6.80
88300 <1% 26 $3.75
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 228 $3.74
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,699 $1.47
3046F 0% 335 $0.00
3050F 0% 1,039 $0.00
3078F 0% 1,026 $0.00
3051F 0% 329 $0.00
3077F 0% 30 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 14 $0.00
G0204 Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral 0% 13 $0.00
3060F 0% 288 $0.00
3048F 0% 2,148 $0.00
3052F 0% 187 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 69 $0.00
3011F 0% 4,808 $0.00
3061F 0% 502 $0.00
3049F 0% 1,167 $0.00
3044F 0% 1,741 $0.00
3074F 0% 1,077 $0.00
3079F 0% 40 $0.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialROSENBERGER, ROBERT (CFO)
Same official

Other billing entities under ROSENBERGER, ROBERT

Full network →
ProviderLocationPaid
Adena Health SystemChillicothe, OH$98.12M
Valley Medical Facilities, INC.Sewickley, PA$19.37M
Valley Medical Facilities INCSewickley, PA$4.22M
Valley Medical Facilities, INC.Sewickley, PA$3.71M
Valley Medical Facilities, INC.Mc Kees Rocks, PA$1.86M
Valley Medical Facilities INCMc Kees Rocks, PA$80K
Valley Medical Facilities, INC.Wexford, PA$32K
Valley Medical Facilities, INC.Bellevue, PA$1K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.